On the other hand, LOX-PP decreased the levels of NF-κB and cyclin D1 in Her-2/neu-transformed NF639 breast cancer cells and MIA PaCa-2 pancreatic cancer cells, together with a reduction in migration and growth in soft agar (105). Here, NFKB1 is linked to breast carcinoma.